• Home
• Environmental Health
• Health, Diseases & Disabilities
• Reproductive Health

Reproductive Health Research and Resources

In considering reproductive health, we focus especially on exposures to environmental contaminants, particularly during critical periods of development. We also note other important factors that can influence reproductive health outcomes, such as nutrition and stress.

On this page, we summarize what the emerging science says about links between these exposures and all aspects of reproductive health—conception, fertility, pregnancy, adolescent development and adult health.¹ Environmental impacts can be lifelong or even passed on to future generations.

Environmental Contributors

Reproductive Toxicants

Exposure to environmental toxicants is linked with various reproductive diseases and disorders, many of which harm a person’s ability to conceive and complete a successful pregnancy.

Toxicants and their reproductive health effects are grouped by the strength of evidence (strong or good). Unless noted otherwise, toxicants are from CHE's Toxicant and Disease Database.²  

 Notes:

• The research on these and other toxicants is rapidly expanding and being updated.
• Reproductive effects may result from exposures before conception, as a fetus, as an infant or child, during puberty, or as an adult.
• More information about the links between toxicants and reproductive health, including links with more limited evidence, are in CHE's Toxicant and Disease Database.

Nutrition and Birth Outcomes

Poor maternal nutrition can affect birth outcomes, but the relationship between the two is also influenced by characteristics that vary among populations, including demographic factors, socioeconomic status and genetic drivers. Improving nutritional status is known to reduce mortality, morbidity, and health-care costs associated with adverse pregnancy outcomes, including low birth weight, preterm birth and intrauterine growth restriction (IUGR). Aside from pregnancies with congenital anomalies, these three outcomes are the leading causes of neonatal death, and all three can result in a predisposition to chronic disease in adulthood. Nutritional status and low birth weight are especially important in developing countries where 98 percent of all neonatal deaths occur. Improved nutrition in nutrient-deficient mothers is accompanied by a corresponding reduction in adverse birth outcomes.¹⁹

Poverty and Other Stressful Environments

Low-income families are more likely to experience nutritional deficiencies and, especially in developing countries, preterm birth, low birth weight and IUGR outcomes. Low-income status is also associated with other factors that are associated with poor birth outcomes, such as smoking, alcohol and substance abuse, infections and a history of preterm births. It is unclear how these factors interact with low nutritional status.²⁰

Pregnant women with high stress and anxiety levels are at increased risk for miscarriage, preeclampsia (a serious pregnancy complication characterized by high blood pressure and signs of damage to kidneys or other organ systems),²¹ preterm labor, fetal growth restriction (related to low birth weight) and birth defects.²²

Health Conditions and Pregnancy

Before Pregnancy

Many pre-conception maternal health conditions are associated with poor birth outcomes. They include these, all from the US Office of Women's Health unless noted otherwise:²³

During Pregnancy

Several maternal health conditions during pregnancy increase the risk for poor birth outcomes.²⁵

Chronic Disease, Infertility and Pregnancy Loss

Autoimmune conditions have the potential to impact fertility by causing reproductive organs to fail or inhibiting the ability of a fertilized egg to implant; they may even cause pregnancy loss.²⁹

Though causal links have not been identified, between 10 and 30 percent of women with premature ovarian failure also have an autoimmune disease. In males, autoimmune orchitis (inflammation of the testes) can cause infertility.³⁰

Other examples of chronic diseases and conditions that can contribute to infertility are cancer,³¹ chronic kidney disease,³² inflammatory bowel disease (IBD)³³ and obesity.³⁴

Infection and Infectious Disease

Mycoplasma genitalium is a pathogenic bacterium that may be sexually transmitted; it is easily treated with antibiotics. A two-fold increase in the risk of pelvic inflammatory disease, preterm birth and spontaneous abortion is seen with M. genitalium infection.³⁵ Other examples of infectious diseases and infections that can contribute to pelvic inflammatory disease and infertility are Chlamydia trachomatis,³⁶ gonorrhea³⁷ and Trichomonas vaginalis.³⁸ More information about infection and pregnancy outcomes is available on our Global Environment page and from the US Office of Women's Health.

Timing of Exposures

The developmental stage of an individual at the time of an exposure can make a huge difference in the outcome. An exposure that could cause severe malformations for a fetus could be harmless to an individual later in life. In general, exposures early in life (embryo, fetus, infant and child) and again during puberty are more likely to cause harm to the developing and maturing reproductive system than exposures at other times. However, because hormone levels fluctuate throughout life and regulate many reproductive functions, substances and exposures that impact our hormones can have effects throughout our reproductive lives.

Critical windows.  According to the World Health Organization, a critical window of susceptibility is a "sensitive time interval during development when environmental exposures can interfere with physiology of cell, tissue, or organ." These windows include periods in which cells are growing rapidly, tissues are forming, and the young body is still without most protective capabilities, such as an immune system, blood brain barrier, or DNA repair system.  

The Critical Windows of Development³⁹ timeline from The Endocrine Disruption Exchange⁴⁰ shows how exposures to certain chemicals can affect various anatomical systems (including reproductive and endocrine systems) at different stages of prenatal development.

Genetics and Infertility

Studying the genetics of infertility is a large endeavor: There are around 2,300 genes expressed in the testis alone. That said, up to 50 percent of infertility cases may be caused by genetic errors including sickle cell anemia and fragile X syndrome. Mutations in genes involved in steroid synthesis and energy pathways can also cause infertility.

Genetically caused infertility can arise from more than just single gene errors. Alterations in chromosomes, the number of gene copies and epigenetic disorders can all impact fertility.⁴² More information about genetics is on our Gene-Environment Interactions webpage.

Pregnancy and the Environment

“Women are the first environment. We are an embodiment of our Mother Earth. From the bodies of women flows the relationship of the generations both to society and the natural world.”

  -Katsi Cook, Mohawk midwife and reproductive justice activist

As Cook states, mothers embody their relationships with the environment in a number of ways:

1. Many environmental toxicants, such as lead and PCBs, can accumulate in a mother’s body over time, both prior to and during pregnancy. These toxicants may then be passed down to her children through her blood and breast milk.
2. Stress responses and some chemicals can induce changes in a mother’s genetic makeup, which can also be passed on to future generations. See Gene-Environment Interactions.
3. Early exposures (in utero, in infancy, in adolescence) that impact a woman’s reproductive health can impact her pregnancy outcomes.

As such, a mother’s health before, during, and after pregnancy are all crucial in determining the health of her child. Environmental exposures that happen at all stages in a woman’s life are relevant to pregnancy.

Pregnancy Complications

Complications during pregnancy can have pervasive and long-lasting health impacts on the child. Adverse pregnancy outcomes such as miscarriage, stillbirth, and birth defects can be a deeply traumatic experience for expecting parents, and can also pose a physical threat to mothers. Pregnancy outcomes are the results of genetic, endocrine, behavioral, and/or environmental factors.

Some chemicals and other types of environmental toxicants can impact fetal health and are called fetotoxicants. Environmental exposures can also impact fetal growth and can contribute to pregnancy loss/fetal death. We do not discuss birth defects, other than defects of reproductive tracts, nor cancers of the reproductive system on this page; see separate pages on Birth Defects and Cancer.

Impaired Fetal Growth, Low Birth Weight, and Preterm Birth

Impaired fetal growth⁴³ includes low birth weight and small for gestational age (SGE). Impaired fetal growth can lead to an increased risk of many childhood and adult illnesses.⁴⁴

Impaired fetal growth often coincides with preterm birth,⁴⁵ the birth of an infant before 37 weeks of pregnancy. In 2013, about one in nine births in the United States was preterm, with slightly lower rates with white births and higher rates with black and Hispanic births.⁴⁶ Preterm birth is the greatest contributor to infant death and a leading cause of long-term neurological disabilities in children.⁴⁷ Preterm birth is also associated with a number of other health issues.

Pregnancy Loss (Miscarriage, Stillbirth)

In the United States, both miscarriage and stillbirth refer to the unplanned loss of a pregnancy, with miscarriage at less than 20 weeks of pregnancy and stillbirth at 20 or more weeks of pregnancy.⁴⁸ Among women with a known pregnancy, 15 to 20 percent will have a miscarriage, while about one percent will experience a stillbirth.⁴⁹

Miscarriages and stillbirths may occur for many reasons:

• The egg or sperm may be damaged, making fertilization difficult or impossible and/or preventing the fertilized egg from surviving afterwards.
• A problem may exist in the hormone balances needed to maintain the pregnancy.
• The fetus may not have developed normally.
• Physical problems may exist with the uterus or cervix.⁵⁰

Ectopic Pregnancy

In an ectopic pregnancy, a fertilized egg implants in the mother's body somewhere other than the main cavity of the uterus.⁵¹ Often, the egg implants in a fallopian tube, which is known as a tubal pregnancy. This situation can be dangerous to the mother, and the embryo will not be able to survive.

Issues in Fertility and Sexual Health

Infertility is the inability to conceive after one year of unprotected sex.⁵² While an increase in infertility, especially in industrialized nations, has been reported, changing social and behavioral variables—such as increased access to contraception, economic improvements, improved social standing of women, and delayed marriage—make conclusions difficult.⁵³ Some researchers suggest that lifestyle changes in industrialized nations, accompanied by a gradual increase in the number and amount of environmental toxicants people are exposed to over the years, could contribute to overall decreases in fertility.⁵⁴

While fertility is influenced by many factors—including aging, acute and chronic diseases, treatments for certain conditions, and behavior—environmental toxicants are known or suspected to affect fertility in both men and women. Here we focus on common diseases and disorders of the female and male reproductive tracts with good or strong links to environmental toxicants.

Diseases and Disorders of the Female Reproductive System

Endometriosis occurs when the tissue that lines the inside of the uterus (the endometrium), or endometrial-like tissue, grows outside the uterus on other parts of the body. This condition affects between 10 and 15 percent of reproductive-age women and is one of the leading causes of infertility, with about 30 to 40 percent of those affected being infertile.⁵⁵

Uterine fibroids (leiomyoma) are made of muscle cells and other tissues that grow in and around the wall of the uterus and can cause pelvic pain, abnormally heavy periods, abnormal uterine bleeding, infertility and complications in pregnancy.⁵⁶ This condition occurs in 25 to 50 percent of all women, with some estimates even higher.

Polycystic ovarian syndrome (PCOS) is characterized by irregular periods, androgen excess, pelvic pain, and ovarian cysts. By some measurements, the prevalence of PCOS is as high as 15 to 20 percent of women. Women with PCOS have a higher risk of developing diabetes, endometrial cancer, infertility, miscarriage, and high blood pressure.⁵⁷

Early onset menopause is menopause before age 40. Some medical treatments can cause early menopause, including chemotherapy or pelvic radiation treatments for cancer, surgical removal of both ovaries, and hysterectomy (removal of the uterus). Some autoimmune diseases can lead to early menopause, and there may be genetic factors, also. Besides reduced or eliminated fertility, early onset menopause can also increase a woman's risk of osteoporosis and heart disease.⁵⁸

Menstrual disorders include amenorrhea (lack of a period), dysmenorrhea (painful periods), and abnormal uterine bleeding. Amenorrhea is normal and expected during pregnancy and lactation (breastfeeding), but at other times may indicate a medical condition needing attention. Some conditions that can lead to amenorrhea include extreme weight loss, eating disorders, excessive exercising, and stress. Dysmenorrhea may be caused by uterine fibroids or endometriosis, especially in older women. Abnormal uterine bleeding may be caused by hormonal changes, although more serious underlying medical conditions can also cause abnormal bleeding.⁵⁹

Diseases and Disorders of the Male Reproductive System

Hypospadias is a birth defect in boys where the opening of the urethra (the tube that carries urine from the bladder to the outside of the body) is not located at the tip of the penis. The abnormal opening can form anywhere from just below the end of the penis to the scrotum. It is estimated that about five out of every 1,000 boys born in the United States have hypospadias, making it one of the most common birth defects.⁶⁰

Cryptorchidism, or undescended testicles, occurs when one or both testicles do not drop down into the scrotum before birth. It is the most common genital problem in pediatrics.⁶¹ About one third of premature boys have an undescended testicle on at least one side, compared to two to eight percent of full-terms boys. If left untreated, cryptorchidism can impact the testis over time, reducing spermatogenesis and resulting in reduced fertility in adulthood.⁶²

Erectile dysfunction, or ED, is the consistent or recurrent inability to attain and/or maintain a penile erection sufficient for sexual performance.⁶³ Many factors can increase risks for ED, including these:⁶⁴

• aging, although aging itself does not cause ED
• being overweight
• injuries, including from prolonged bicycling
• some medications, including blood pressure medications, antihistamines, antidepressants, tranquilizers, appetite suppressants, and ulcer medications
• stress, depresson or other psychological states
• drug or alcohol use
• sex hormone levels
• other medical conditions including hypertension, cardiovascular diseases, atherosclerosis, and diabetes mellitus

Other Areas of Concern in Reproductive Health

Altered Sex Ratio

The ratio of male to female offspring at birth is typically 104 to 107 boys for every 100 girls, excluding societies where selective abortion skews the sex ratio. Anything outside this range is considered an altered sex ratio. Although research is fairly limited, some studies have found associations between certain chemicals and altered sex ratio. Because many of these chemicals affect fertility, departures from this fairly stable ratio could reflect damage to reproductive systems beyond the altered sex ratio.

Timing of Puberty Onset in Girls

The age of puberty onset appears to have declined in several industrialized nations over the last half century. In the United States, girls get their first periods (menarche) a few months earlier than they did 40 to 50 years ago, and they develop breasts (thelarche) one to two years earlier.⁶⁵ The hormonal cues that initiate the onset of puberty are sensitive to a variety of influences, including obesity, nutrition, and stress, as well as exposure to environmental pollutants.⁶⁶

Breastfeeding

Hormone levels during puberty, pregnancy and lactation regulate the development of breast tissue and the ability to produce sufficient milk for an infant. The mother's states of well-being, including stress, fatigue, and nutrition, are known to affect milk production.⁶⁷ Obesity may also impact the initiation and duration of lactation, as can race, age, marital status, education, and socioeconomics.⁶⁸

The numerous health benefits of breastfeeding are well documented:

• Babies who are breastfed tend to have higher IQs than babies who are not breastfed.
• Breastfeeding lowers the risk of death from infectious, gastrointestinal and allergic diseases in babies.
• Breastfeeding may reduce babies' risk of obesity.⁶⁹

Mothers also benefit substantially from breastfeeding, with a lower risk of postpartum hemorrhage and depression, as well as reduced blood pressure and stress. Long-term effects include reduced risk of breast and ovarian cancers, hypertension, and type 2 diabetes.⁷⁰

Unfortunately, in addition to important enzymes and nutrients, breast milk can also carry toxic chemicals, especially persistent organic pollutants (POPs). Chemicals accumulate in a mother’s body throughout her life and can be passed to the baby both through the placenta and in breast milk.

See more about environmental contributors to reproductive health in the list of CHE publications and Dig Deeper resources in the right sidebar.

CHE's Work on Reproductive Health and Fertility 

From Ali Carlson's How CHE Fertility Came into Being, and How It Helped Shape the Reproductive Health & Environmental Health Fields:

CHE Fertility's collaborative work essentially defined the field of reproductive environmental health. Without CHE and the expertise of the pioneering researchers, health professionals and advocates that it attracted, the emergence of what is now a highly robust field would likely have taken years if not possibly decades more to develop. In short, CHE Fertility was at the center of launching an effective, multidiscipline endeavor that bridged science with medicine, health advocacy and policy that ultimately put reproductive environmental health on the map of priorities for scientists, health professionals and concerned citizens alike.

The mix of leading stakeholders that CHE convened developed what is now standard fare at CHE: science-focused teleconferences; an interactive ScienceServ; a carefully culled and tailored scientific abstracts database; regular newsletters; and expert resources for media. They also created an informally managed "speakers bureau" for stakeholder meetings and programs, Congressional testimony, etc. The pioneering actions that made CHE Fertility so successful included:

• Organizing a range of stakeholders around credible science, in particular establishing partnerships between federal agency leaders, advocates, scientists and doctors
• Bringing heft and validity to the concerns raised by the science, signaling its importance to decision-makers in medicine, policy and funding
• Propagating the logic and far greater efficiency of investing in upstream disease prevention as an important complement to the 96% of dollars invested in disease in the US going toward treatment
• Galvanizing a large choir of sophisticated messengers and catalysts who inform policy debates, influence research agendas and funding priorities as well as clinical care
• Engaging a set of leading professional associations until they paid attention. Those societies upped the ante, becoming critical voices in health care sector and on Capitol Hill, with the steady assistance from CHE Fertility partners
• Providing an important platform for nurses, who became some of the most proactive and effective voices for improved understanding and practice
• Pressing for research agendas (and funding) to fill critical knowledge gaps

Also see the list of CHE's publications related to reproductive health and fertility to the right.

Vallombrosa Statement

Vallombrosa Consensus Statement on Environmental Contaminants and Human Fertility Compromise, 2005. CHE's Fertility/Early Pregnancy Compromise Work Group partnered with Linda C. Giudice, MD, PhD, to convene a small multidisciplinary group of experts at the Vallombrosa Retreat Center in Menlo Park, California. The group's goal was to assess what the science tells us about the contribution of environmental contaminants—specifically synthetic compounds and heavy metals—to human infertility and associated health conditions.

Summit on Environmental Challenges to Reproductive Health and Fertility

In 2007, CHE joined the University of California, San Francisco, in sponsoring an environmental reproductive health summit. This conference was designed for clinical researchers and clinicians/health professionals, scientists; allied and public health professionals; policy makers, government; leaders from patient advocacy, women's health, community and worker health, environment, reproductive advocacy, and environmental justice; and environment/health funders. Participants exchanged the latest research around environmental contaminants and reproductive health, discussed how the science impacts public health, education, policy, and the health care system and explored mutual areas of collaboration among the diverse constituencies participating in the summit. Proceedings were published in 2008.⁷¹

Women's Reproductive Health and the Environment Workshop

Meeting in January 2008, the Women’s Reproductive Health and the Environment Workshop fostered a collaboration of eminent and up-and-coming scientists specializing in women’s reproductive health. Organized by the CHE in partnership with the University of Florida and the University of California, San Francisco's Program on Reproductive Health and the Environment (PRHE), his invitational workshop had three goals:

1. Assess the key science linking environmental contaminant exposures to reproductive health outcomes currently being reported at ever greater rates in women and girls.  In particular, assess xenobiotics and phytoestrogens and the deleterious effects of these compounds on normal ovarian, uterine, breast, and hypothalamic/pituitary function.
2. Identify research directions that will fill current gaps in the scientific understanding in this field.
3. Translate this information for a lay audience of journalists, policymakers, NGOs, community groups and others who can develop a strategy for prevention and intervention.

Proceedings were published in 2008.⁷² The conference also led to the publication of a report for a non-scientific audience: Girl, Disrupted: Hormone Disruptors and Women's Reproductive Health and a summary brochure in two versions: a trifold brochure for a general audience: Hormone Disruptors and Women's Health: Reasons for Concern and an annotated version for researchers.

Workshop on Navigating the Scientific Evidence to Improve Prevention

In August 2009, The University of California, San Francisco (UCSF) Program on Reproductive Health and the Environment (PRHE), CHE, the Association of Reproductive Health Professionals (ARHP), the Magee-Womens Hospital of the University of Pittsburgh Medical Center, the UCSF Pediatric Environmental Health Specialty Unit (PEHSU) and WorkSafe hosted this workshop. The goal was to translate the emerging science in environmental reproductive health into timely action in clinical and policy arenas. The workshop achieved consensus on the outline of the Navigation Guide,⁷³ which was published in 2011.

Women's Environmental Reproductive Health Consortium

CHE's Reproductive Health ScienceServ has taken a leading role in the Women's Environmental Reproductive Health Consortium, which convenes researchers from the National Institutes of Environmental Health Sciences Intramural Research Division and grantees at academic institutions across the United States receiving funds through the NIEHS Division of Extramural Research & Training. The consortium seeks to build better interactions and collaborations among scientists in order to form mutually beneficial partnerships, share best practices, databases, and tissue banks, and explore translational strategies that magnify the impact of scientific findings. For more information, please contact Karin Russ.

2012 WERHC meeting participants

This page was last revised by Nancy Hepp and student intern Jessica Couch in September 2016. 

CHE invites our partners to submit corrections and clarifications to this page. Please include links to research to support your submissions through the comment form on our Contact page.

1. Woodruff TJ et al. Proceedings of the Summit on Environmental Challenges to Reproductive Health and Fertility: executive summary. Fertility and Sterility. February 2008; 89(2):281-300.
2. Janssen S, Solomon G, Schettler T. Toxicant and Disease Database. Collaborative on Health and the Environment. 2011.
3. Schettler T. Environmental exposures, infertility, and related reproductive disorders: an update. Collaborative on Health and the Environment. October 2011.
4. Terrell M, Hartnett K, Marcus M. Can environmental or occupational hazards alter the sex ratio at birth? A systematic review. Emerging Health Threats Journal. 2011; 4: 7109.
5. Poursafa P, Ataei E, Kelishadi R. A systematic review on the effects of environmental exposure to some organohalogens and phthalates on early puberty. Journal of Research in Medical Sciences: The Official Journal of Isfahan University of Medical Sciences. 2015; 20(6):613-618.
6. Windham GC et al. Brominated flame retardants and other persistent organohalogenated compounds in relation to timing of puberty in a longitudinal study of girls. Environmental Health Perspectives. 2015 Oct;123(10):1046-52.
7. Behie AM, O'Donnell MH. Prenatal smoking and age at menarche: influence of the prenatal environment on the timing of puberty. Human Reproduction. 2015; 30(4):957-62; Yang S et al. Childhood passive smoking exposure and age at menarche in Chinese women who had never smoked: the Guangzhou Biobank Cohort Study. PLoS One. 2015 Jul 17;10(7):e0130429.
8. Surgeon General. 50 Years of Progress Surgeon General Report. US Department of Health and Human Services. 2014. Viewed June 11, 2016.
9. Benagiano G, Brosens I. In utero exposure and endometriosis. The Journal of Maternal-Fetal & Neonatal Medicine. 2014; 27(3):303-8.
10. US National Library of Medicine. Biphenyls (PCBs). Tox Town. Viewed July 13, 2016.
11. Marie C, Vendittelli F, Sauvant-Rochat MP. Obstetrical outcomes and biomarkers to assess exposure to phthalates: a review. Environment International. 2015 Oct;83:116-36; Habert R et al. Adverse effects of endocrine disruptors on the foetal testis development: focus on the phthalates. Folia Histochemica et Cytobiologica. 2009;47(5):S67-74; Sathyanarayana S et al. First trimester phthalate exposure and male newborn genital anomalies. Environmental Research. 2016 Aug 18.
12. Chen Zee E et al. [Impact of endocrine disrupting chemicals on birth outcomes]. Gynécologie, Obstétrique & Rertilité. 2013 Oct;41(10):601-10.
13. Chen Zee E et al. [Impact of endocrine disrupting chemicals on birth outcomes]. Gynécologie, Obstétrique & Rertilité. 2013 Oct;41(10):601-10.
14. Minnes S, Lang A, Singer L. Prenatal tobacco, marijuana, stimulant, and opiate exposure: outcomes and practice implications. Addiction Science & Clinical Practice. July 2011; 6(1): 57–70
15. Chen Zee E et al. [Impact of endocrine disrupting chemicals on birth outcomes]. Gynécologie, Obstétrique & Rertilité. 2013 Oct;41(10):601-10.
16. Johnson PI et al. The Navigation Guide—evidence-based medicine meets environmental health: systematic review of human evidence for PFOA effects on fetal growth. Environmental Health Perspectives. 2014 Oct;122(10):1040-51.
17. Rutkowska A, Rachoń D. Bisphenol A (BPA) and its potential role in the pathogenesis of the polycystic ovary syndrome (PCOS). Gynecological Endocrinology. 2014 Apr;30(4):260-5.
18. Abu-Saad K, Fraser D. Maternal nutrition and birth outcomes. Epidemiologic Reviews. 2010:32;5-25; Mayo Clinic. Healthy Lifestyle: Pregnancy week by week. Viewed October 26 2016.
19. Abu-Saad K, Fraser D. Maternal nutrition and birth outcomes. Epidemiologic Reviews. 2010:32;5-25.
20. Abu-Saad K, Fraser D. Maternal nutrition and birth outcomes. Epidemiologic Reviews. 2010:32;5-25.
21. Mayo Clinic Staff.Preeclampsia. Mayo Clinic. Viewed September 13, 2016.
22. Mulder EJ et al. Prenatal maternal stress: effects on pregnancy and the (unborn) child. Early Human Development. 2002 Dec;70(1-2):3-14.
23. Office of Women’s Health. Pregnancy complications. Womenshealth.gov. 2010. Viewed September 12, 2016.
24. Negrato CA, Mattar R, Gomes MB. Adverse pregnancy outcomes in women with diabetes. Diabetology & Metabolic Syndrome. 2012 Sep 11;4(1):41.
25. Reproductive Health. Pregnancy Complications. Centers for Disease Control and Prevention. 2016. Viewed September 12, 2016.
26. Codner E, Merino PM, Tena-Sempere M. Female reproduction and type 1 diabetes: from mechanisms to clinical findings. Human Reproduction Update. 2012 Sep-Oct;18(5):568-85
27. Ding GL et al. The effects of diabetes on male fertility and epigenetic regulation during spermatogenesis. Asian Journal of Andrology. 2015 Nov-Dec;17(6):948-53.
28. Oktem O et al. Ovarian function and reproductive outcomes of female patients with systemic lupus erythematosus and the strategies to preserve their fertility. Obstetrical & Gynecological Survey. 2015 Mar;70(3):196-210.
29. Carp HJA, Selmi C, Shoenfeld Y. The autoimmune bases of infertility and pregnancy loss. Journal of Autoimmunity. 2012:38(2);J266-J274.
    
30. Carp HJA, Selmi C, Shoenfeld Y. The autoimmune bases of infertility and pregnancy loss. Journal of Autoimmunity. 2012:38(2);J266-J274.
31. Salama M et al. Updates in preserving reproductive potential of prepubertal girls with cancer: systematic review. Critical Reviews in Oncology/Hematology. 2016 Jul;103:10-21.
32. Kuczera P, Adamczak M, Wiecek A. Endocrine abnormalities in patients with chronic kidney disease. Prilozi (Makedonska Akademija na Naukite i Umetnostite. Oddelenie za Medicinski Nauki). 2015;36(2):109-18.
33. Kokoszko-Bilska A, Sobkiewicz S, Fichna J. Inflammatory bowel diseases and reproductive health. Pharmacological Reports. 2016 Aug;68(4):859-64.
34. Manna P, Jain SK. Obesity, oxidative stress, adipose tissue dysfunction, and the associated health risks: causes and therapeutic strategies. Metabolic Syndrome and Related Disorders. 2015 Dec;13(10):423-44.
35. Lis R, Rowhani-Rahbar A, Manhart LE. Mycoplasma genitalium infection and female reproductive tract disease: a meta-analysis. Clinical Infectious Disease. 2015;61(3):418-426.
36. Ziklo N et al. Chlamydia trachomatis genital tract infections: when host immune response and the microbiome collide. Trends in Microbiology. 2016 Sep;24(9):750-65.
37. Baarda BI, Sikora AE. Proteomics of Neisseria gonorrhoeae: the treasure hunt for countermeasures against an old disease. Frontiers in Microbiology. 2015 Oct 26;6:1190.
38. Vieira Pde B et al. Natural and synthetic compound anti-Trichomonas vaginalis: an update review. Parasitology Research. 2015 Apr;114(4):1249-61.
39. Endocrine Disruption Exchange. Critical windows of development timeline. Viewed June 16, 2016.
40. Endocrine Disruption Exchange. Home. Viewed June 16, 2016.
41. Zorrilla M, Yatsenko A. The genetics of infertility: current status of the field. Current Genetic Medicine Reports. 2013:1;247-260.
42. Zorrilla M, Yatsenko A. The genetics of infertility: current status of the field. Current Genetic Medicine Reports. 2013:1;247-260.
43. US National Library of Medicine. Intrauterine growth restriction. MedlinePlus Medical Encyclopedia. November 2014. www.nlm.nih.gov/medlineplus/ency/article/001500.htm. Viewed June 29, 2016.
44. Centers for Disease Control and Prevention. Preterm birth. December 2015. www.cdc.gov/reproductivehealth/MaternalInfantHealth/PretermBirth.htm. Viewed June 29, 2016.
45. Centers for Disease Control and Prevention. Preterm birth. December 2015. www.cdc.gov/reproductivehealth/MaternalInfantHealth/PretermBirth.htm Viewed June 29, 2016.
46. MacDorman M, Gregory E. Fetal and Perinatal Mortality: United States, 2013. CDC National Vital Statistics Reports. July 23, 2015. Viewed June 29, 2016.
47. Centers for Disease Control and Prevention. Preterm birth. December 2015. www.cdc.gov/reproductivehealth/MaternalInfantHealth/PretermBirth.htm Viewed June 29, 2016.
48. US National Library of Medicine. Miscarriage: MedlinePlus Medical Encyclopedia. November 2014. www.nlm.nih.gov/medlineplus/ency/article/001488.htm. Viewed June 16, 2016; Centers for Disease Control and Prevention. Stillbirth. June 2016. www.cdc.gov/ncbddd/stillbirth/index.html. Viewed June 16, 2016; Centers for Disease Control and Prevention. Fetal Deaths. 2016.http://www.cdc.gov/nchs/nvss/fetal_death.htm. Viewed June 16, 2016.
49. US National Library of Medicine. Miscarriage: MedlinePlus Medical Encyclopedia. November 2014. www.nlm.nih.gov/medlineplus/ency/article/001488.htm. Viewed June 16, 2016.
50. National Institute on Occupational Safety and Health. The Effects of Workplace Hazards on Female Reproductive Health. February 1999. www.cdc.gov/niosh/docs/99-104/pdfs/99-104.pdf. Viewed July 11, 2016.
51. Mayo Clinic. Ectopic pregnancy. www.mayoclinic.org/diseases-conditions/ectopic-pregnancy/basics/definition/con-20024262. Viewed July 20, 2016.
52. Centers for Disease Control and Prevention. Infertility FAQs. 2016. http://www.cdc.gov/reproductivehealth/infertility/. Viewed June 10, 2016.
53. Schettler T. Environmental exposures, infertility, and related reproductive disorders: an update. Collaborative on Health and the Environment. October 2011; Mosher WD. Fertility and family planning in the United States: insights from the National Survey of Family Growth. Family Planning Perspectives. 1988 Sep-Oct;20(5):207-17; Singarimbun M. The conflicting effects of delayed marriage and declining divorce rates on cumulative fertility in Indonesia. Asian and Pacific Population Forum. 1992 Spring;6(1):5-14, 25-6.
54. Schettler T. Environmental exposures, infertility, and related reproductive disorders: an update. Collaborative on Health and the Environment. October 2011.
55. US National Library of Medicine. Endometriosis. 2016. www.nlm.nih.gov/medlineplus/endometriosis.html. Viewed June 14, 2016.
56. US National Library of Medicine. Uterine Fibroids: MedlinePlus. July 2014. www.nlm.nih.gov/medlineplus/uterinefibroids.html, Viewed June 15, 2016.
57. Sirmans SM, Pate KA. Epidemiology, diagnosis, and management of polycystic ovary syndrome. Clinical Epidemiology. 2014;6:1-13.
58. Office on Women's Health, US Department of Health and Human Services. Early menopause (premature menopause). September 22, 2010. http://womenshealth.gov/menopause/early-premature-menopause/. Viewed July 21, 2016.
59. Office on Women's Health, US Department of Health and Human Services. Menstruation and the menstrual cycle fact sheet September 22, 2010. http://www.womenshealth.gov/publications/our-publications/fact-sheet/menstruation.html. Viewed December 23, 2014.
60. CDC. Facts about Hypospadias. 2016. www.cdc.gov/ncbddd/birthdefects/hypospadias.html, Viewed June 10, 2016.
61. PubMed Health. Undescended testicles (Cryptorchidism). www.ncbi.nlm.nih.gov/pubmedhealth/PMHT0025071/. Viewed June 29, 2016.
62. Niedzielski JK, Oszukowska E, & Słowikowska-Hilczer J. Undescended testis – current trends and guidelines: a review of the literature. Archives of Medical Science. 2016; (3):667-677.
63. Freeman K. Arsenic and erectile dysfunction: drinking contaminated well water increases risk. Environmental Health Perspectives. 2008 Apr; 116(4): A172.
64. National Institute of Diabetes and Digestive and Kidney Diseases. Erectile Dysfunction. November 2015. www.niddk.nih.gov/health-information/health-topics/urologic-disease/erectile-dysfunction/Pages/facts.aspx. Viewed July 22, 2016; Mayo Clinic Staff. Erectile dysfunction. www.mayoclinic.org/diseases-conditions/erectile-dysfunction/basics/risk-factors/con-20034244. Viewed July 22, 2016
65. Collaborative on Health and the Environment. Girl, Disrupted. 2008. Viewed June 15, 2016.
66. Crain DA et al. Female reproductive disorders: the roles of endocrine-disrupting compounds and developmental timing. Fertility and Sterility. 2008 Oct; 90(4):911-40.
67. Wagner CL. Human milk and lactation. Medscape. February 2, 2015. http://emedicine.medscape.com/article/1835675-overview. Viewed July 22, 2016.
68. Lepe M. Effect of maternal obesity on lactation: systematic review. Nutrición Hospitalaria. 2011 Nov-Dec;26(6):1266-9; Thulier D, Mercer J. Variables associated with breastfeeding duration. Journal of  Obstetric, Gynecological and Neonatal Nursing. 2009 May-Jun;38(3):259-68.
    
69. Horta B, Victora C. Long-term Effects of Breastfeeding. World Health Organization. 2013. Viewed July 23, 2016.
70. Lessen R et al. Position of the Academy of Nutrition and Dietetics: promoting and supporting breastfeeding. Journal of the Academy of Nutrition and Dietetics. 2015;115:444-449.
71. Woodruff TJ et al.Proceedings of the Summit on Environmental Challenges to Reproductive Health and Fertility: executive summary. Fertility and Sterility. 2008 Feb;89(2):281-300.
72. Crain DA et al Female reproductive disorders: the roles of endocrine-disrupting compounds and developmental timing. Fertility and Sterility. 2008 Oct;90(4):911-40.
73. Woodruff TJ et al. An evidence-based medicine methodology to bridge the gap between clinical and environmental health sciences. Health Affairs. 2011 May;30(5):931-7.

View All Footnotes

Blog Posts

CHE Publications

Including those created jointly with other organizations

Dig Deeper